register

News - Pharmaceuticals

Involving medication experts is more than a placebo

Health Industry Hub | December 4, 2019 |

Revelations this week that doctors are prescribing medicines they know are not indicated for the conditions the patient has presented with demonstrates why pharmacists must be more actively involved in medication management in Australia.

“Prescribing unnecessary drugs to patients is not good practice in terms of quality use of medicines,” Pharmaceutical Society of Australia National President, Associate Professor Chris Freeman said. “The more medicines a person has to take and manage the more risk there is of a medication related problem.”

“While there may be some situations in which a placebo might help a patient, the research released this week found doctors were most likely to prescribe an antibiotic. Unnecessary prescription of antibiotics can not only cause patients harm but impact on the future effectiveness of these vital medications.”

According to the Australian Institute of Health and Welfare’s (AIHW) Australia’s Health 2018, unnecessary prescribing of antibiotics leads to a higher risk of adverse side effects and increased anti-microbial resistance in the population.

“Anti-microbial resistance means when we get sick in the future, antibiotics will not be able to fight the bacteria causing the infection,” Assoc Professor Freeman explained.

“There is also a cost to the health system every time a placebo medication is prescribed.”

You may also like Novel Australian labs to revolutionise STEMM innovation

Government spending on PBS medicines increased by 11 per cent between 2015-16 and 2016-17 to reach $12.1 billion.

“While the cost of placebo prescribing was not quantified by this research, it clearly places an additional burden on our health care system and may also leave patients out of pocket for no good reason.

“Safe and quality use of medicines was declared a National Health Priority Area last month. The regular prescribing of active placebos – real drugs that won’t address the underlying condition – seems to fly in the face of all we are trying to achieve.

“Increased utilisation of pharmacists as part of a collaborative health care team, including within general practice, will improve medication management and help educate consumers about quality and safe use of medicines.”

Register FREE to receive the latest news, innovations and insights from Health Industry Hub; the only one-stop-hub connecting Australia’s Pharma, MedTech and Biotech industry professionals and its key stakeholders.


Digital & Innovation

Health sector faces new privacy obligations

Health sector faces new privacy obligations

Health Industry Hub | September 11, 2026 |

Healthcare organisations must update their privacy policies by 10 December if they use artificial intelligence (AI) or a computer program […]

More


News - Pharmaceuticals

TGA approves new antibiotic but AMR blind spot remains a critical concern

TGA approves new antibiotic but AMR blind spot remains a critical concern

Health Industry Hub | September 11, 2026 |

The Therapeutic Goods Administration (TGA) has approved a new antibiotic for the treatment of carbapenem-resistant Gram-negative bacterial infections. Developed by […]

More


News - MedTech & Diagnostics

BCAL Diagnostics rejects merger speculation

BCAL Diagnostics rejects merger speculation

Health Industry Hub | September 11, 2026 |

ASX-listed BCAL Diagnostics has moved to quash speculation of a potential three-way merger involving Genetic Signatures and Microba Life Sciences, […]

More


News - Pharmaceuticals

Australia backs infectious disease innovation as US funding faces more cuts

Australia backs infectious disease innovation as US funding faces more cuts

Health Industry Hub | September 11, 2026 |

Biointelect Venturer, a national incubator supporting infectious disease innovation, will open its second funding round later this month, with AUD […]

More


This content is copyright protected. Please subscribe to gain access.